Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,228
Closed -$412K 2784
2025
Q4
$412K Buy
8,228
+1,083
+15% +$52.1K 0.01% 709
2025
Q3
$351K Buy
7,145
+6,832
+2,183% +$350K ﹤0.01% 738
2025
Q2
$16.2K Sell
313
-422
-57% -$19.4K ﹤0.01% 1712
2025
Q1
$34.4K Buy
735
+662
+907% +$34.2K ﹤0.01% 1267
2024
Q4
$3.74K Hold
73
﹤0.01% 1768
2024
Q3
$3.25K Hold
73
﹤0.01% 1775
2024
Q2
$2.93K Hold
73
﹤0.01% 1772
2024
Q1
$2.88K Hold
73
﹤0.01% 1264
2023
Q4
$2.75K Sell
73
-73
-50% -$2.23K ﹤0.01% 1247
2023
Q3
$4.06K Buy
146
+73
+100% +$2.28K ﹤0.01% 1282
2023
Q2
$2.21K Hold
73
﹤0.01% 1131
2023
Q1
$2.25K Hold
73
﹤0.01% 1120
2022
Q4
$2.74K Hold
73
﹤0.01% 1050
2022
Q3
$3K Hold
73
﹤0.01% 1050
2022
Q2
$3K Sell
73
-182
-71% -$7.53K ﹤0.01% 1069
2022
Q1
$12K Buy
+255
New +$12.9K ﹤0.01% 968

Other funds holding SNV

Clearstead Advisors's SNV Position: Q1 2026 in Review

Clearstead Advisors sold out of Synovus (SNV) in Q1 2026, closing a stake of 8,228 shares — an estimated $412K sold.

Clearstead Advisors first reported a position in SNV in Q1 2022 and held it in 16 quarters. The position peaked at $412K in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Clearstead Advisors reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 8,228 Synovus shares in Q1 2026, an estimated $412K.
  • Clearstead Advisors first reported a position in Synovus in Q1 2022 and held it in 16 quarters.
  • Clearstead Advisors's Synovus position peaked at $412K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.